Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention

[1]  R. Sabat,et al.  Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. , 2010, Cytokine & growth factor reviews.

[2]  A. Cavani,et al.  IL-17 and IL-22: siblings, not twins. , 2010, Trends in immunology.

[3]  J. Imura,et al.  Involvement of the IL-22/REG Iα axis in ulcerative colitis , 2010, Laboratory Investigation.

[4]  S. Durham,et al.  Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. , 2009, The Journal of clinical investigation.

[5]  D. Jarrossay,et al.  Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells , 2009, Nature Immunology.

[6]  M. Neurath,et al.  STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing , 2009, The Journal of experimental medicine.

[7]  Lisa C. Zaba,et al.  IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. , 2009, The Journal of allergy and clinical immunology.

[8]  H. Volk,et al.  IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not , 2009, Journal of Molecular Medicine.

[9]  Z. Guo,et al.  Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus , 2009, Annals of the rheumatic diseases.

[10]  C. Akdis,et al.  Differentiation and functional analysis of human T(H)17 cells. , 2009, The Journal of allergy and clinical immunology.

[11]  D. Ye,et al.  Decreased serum IL-22 levels in patients with systemic lupus erythematosus. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[12]  J. Renauld,et al.  Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. , 2009, Arthritis and rheumatism.

[13]  J. Ring,et al.  IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. , 2009, The Journal of allergy and clinical immunology.

[14]  S. Quaglini,et al.  Serum IL-17 levels in patients with allergic rhinitis. , 2008, Journal of Allergy and Clinical Immunology.

[15]  D. Ye,et al.  Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus , 2008, Nature Clinical Practice Rheumatology.

[16]  J. Buer,et al.  The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins , 2008, Nature.

[17]  H. Weiner,et al.  Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor , 2008, Nature.

[18]  M. Fei,et al.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.

[19]  B. Becher,et al.  IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.

[20]  A. Murphy,et al.  Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. , 2007, Immunity.

[21]  C. Akdis,et al.  TH17 cells in the big picture of immunology. , 2007, The Journal of allergy and clinical immunology.

[22]  K. Asadullah,et al.  IL-22 Induces Lipopolysaccharide-Binding Protein in Hepatocytes: A Potential Systemic Role of IL-22 in Crohn’s Disease , 2007, The Journal of Immunology.

[23]  P. Valdez,et al.  Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.

[24]  R. Sabat,et al.  Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. , 2006, Cytokine & growth factor reviews.

[25]  J. Miyazaki,et al.  Hydrodynamic-Based Delivery of an Interleukin-22-Ig Fusion Gene Ameliorates Experimental Autoimmune Myocarditis in Rats1 , 2006, The Journal of Immunology.

[26]  K. Asadullah,et al.  IL‐22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis , 2006, European journal of immunology.

[27]  K. Herrmann,et al.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[28]  M. Neurath,et al.  Both IL‐12p70 and IL‐23 are synthesized during active Crohn's disease and are down‐regulated by treatment with anti‐IL‐12 p40 monoclonal antibody , 2006, Inflammatory bowel diseases.

[29]  P. Boutros,et al.  Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: the case of the aryl hydrocarbon receptor. , 2005, Toxicology and applied pharmacology.

[30]  A. Takayanagi,et al.  Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. , 2005, Gastroenterology.

[31]  M. Abreu,et al.  Defects in mucosal immunity leading to Crohn's disease , 2005, Immunological reviews.

[32]  K. Hiromura,et al.  Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. , 2005, Arthritis and rheumatism.

[33]  K. Asadullah,et al.  IL-22 increases the innate immunity of tissues. , 2004, Immunity.

[34]  R. Sun,et al.  Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.

[35]  L. Armstrong,et al.  Interleukin-22: a potential immunomodulatory molecule in the lung. , 2004, American journal of respiratory cell and molecular biology.

[36]  S. Kotenko,et al.  The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. , 2004, Cytokine & growth factor reviews.

[37]  B. Gao,et al.  Hydrodynamic Gene Delivery of Interleukin-22 Protects the Mouse Liver from Concanavalin A-, Carbon Tetrachloride-, and Fas Ligand-induced Injury via Activation of Stat3 Interleukin-22 (il-22) Is a Recently Identified T Cell-derived Cytokine Whose Biological Significance Remains Obscure. Previously, , 2022 .

[38]  J. Renauld.  Class II cytokine receptors and their ligands: Key antiviral and inflammatory modulators , 2003, Nature Reviews Immunology.

[39]  Diane Lejeune,et al.  Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell Line , 2002, The Journal of Biological Chemistry.

[40]  K. Asadullah,et al.  Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members? , 2002, The Journal of Immunology.

[41]  J. Renauld,et al.  IL-TIF/IL-22: genomic organization and mapping of the human and mouse genes , 2000, Genes and Immunity.

[42]  Zemin Zhang,et al.  Interleukin (IL)-22, a Novel Human Cytokine That Signals through the Interferon Receptor-related Proteins CRF2–4 and IL-22R* , 2000, The Journal of Biological Chemistry.

[43]  J. Renauld,et al.  Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Jamila Louahed,et al.  Cloning and Characterization of IL-10-Related T Cell-Derived Inducible Factor (IL-TIF), a Novel Cytokine Structurally Related to IL-10 and Inducible by IL-91 , 2000, The Journal of Immunology.

[45]  J. Dayer,et al.  Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis , 1995 .

[46]  J. Dayer,et al.  Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. , 1995, Arthritis and rheumatism.